Teladoc Health Inc
NYSE:TDOC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.51
14.33
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Teladoc Health Inc
In the bustling landscape of digital healthcare, Teladoc Health Inc. stands as a pioneering beacon, revolutionizing how medical services are delivered and consumed. Originally founded in 2002 in Dallas, Texas, Teladoc began as a straightforward telemedicine platform offering virtual doctor visits via phone and video calls. Over the years, it has adeptly expanded to provide a comprehensive suite of services, including expert medical opinions, AI-driven health analytics, and management of chronic diseases. Through strategic acquisitions, such as the purchase of Livongo Health, Teladoc broadened its offerings to encompass behavioral health and chronic condition management, thereby creating a holistic ecosystem of care. This integration of services is tailored to meet the diverse health needs of its clients, ranging from individual consumers to large employers and health plans.
Teladoc's business model hinges on a subscription-based framework, primarily targeting employers and insurance companies who offer their digital healthcare platform as a valuable benefit to their employees or policyholders. By charging these institutional clients a recurring fee, and also collecting per-visit fees from individuals, Teladoc ensures a steady and reliable revenue stream. With the growing acceptance and demand for telehealth solutions, particularly heightened by global events like the COVID-19 pandemic, Teladoc has seen a significant increase in utilization rates. This surge underscores the company's strategy of continuous innovation and investment in technology that enhances user experience and outcomes, positioning Teladoc as a leader in the future of healthcare delivery.
In the bustling landscape of digital healthcare, Teladoc Health Inc. stands as a pioneering beacon, revolutionizing how medical services are delivered and consumed. Originally founded in 2002 in Dallas, Texas, Teladoc began as a straightforward telemedicine platform offering virtual doctor visits via phone and video calls. Over the years, it has adeptly expanded to provide a comprehensive suite of services, including expert medical opinions, AI-driven health analytics, and management of chronic diseases. Through strategic acquisitions, such as the purchase of Livongo Health, Teladoc broadened its offerings to encompass behavioral health and chronic condition management, thereby creating a holistic ecosystem of care. This integration of services is tailored to meet the diverse health needs of its clients, ranging from individual consumers to large employers and health plans.
Teladoc's business model hinges on a subscription-based framework, primarily targeting employers and insurance companies who offer their digital healthcare platform as a valuable benefit to their employees or policyholders. By charging these institutional clients a recurring fee, and also collecting per-visit fees from individuals, Teladoc ensures a steady and reliable revenue stream. With the growing acceptance and demand for telehealth solutions, particularly heightened by global events like the COVID-19 pandemic, Teladoc has seen a significant increase in utilization rates. This surge underscores the company's strategy of continuous innovation and investment in technology that enhances user experience and outcomes, positioning Teladoc as a leader in the future of healthcare delivery.
Revenue & EBITDA: Q3 revenue was $626 million, above the midpoint of guidance, while adjusted EBITDA reached $70 million at the high end of guidance.
Segment Performance: Integrated Care revenue grew 1.5% year-over-year with strong international growth; BetterHelp revenue declined due to U.S. cash pay softness but showed progress in insurance and international markets.
Guidance: Full-year 2025 revenue and adjusted EBITDA guidance midpoints remain essentially unchanged; Integrated Care guidance was raised and narrowed, while BetterHelp guidance was narrowed to the lower half of the prior range.
Insurance Rollout: BetterHelp insurance is now live in 7 states and D.C., with early results tracking to expectations and plans for a national rollout by end of 2026.
Chronic Care Enrollment: Chronic care program enrollment rebounded, growing 4% sequentially in Q3 to 1.17 million lives.
Cost Discipline: Technology, development, and G&A expenses improved year-over-year; strong free cash flow was reported.
Strategic Initiatives: Continued innovation in care delivery, AI-driven interventions, and investments in product enhancement are expected to support future growth.
CFO Transition: CFO Mala Murthy will step down next month after six years with Teladoc.
